 DUBLIN, Ireland and FORT WASHINGTON, Pa., Sept. 24, 2021 GLOBE NEWSWIRE -- Nabriva Therapeutics plc NASDAQ: NBRV, a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced data presentation at the Infectious Disease Society of America IDSA IDWeekTM 2021, taking place virtually from September 29 October 3, 2021. 